EUVIMEDEUVIMED entdecken
Crossref

Cancer-associated SF3B1 mutations inhibit mRNA nuclear export by disrupting SF3B1–THOC5 interactions

Gang Liu, Bo Zhao, Yueru Shi, Youzhong Wan iD

The Journal of Biochemistry · 02.12.2024 · 176 (6) · 437-448

DOI: 10.1093/jb/mvae061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Biochemistry, online erschienen am 11.09.2024. Verfasst von Gang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: China-Japan Union Hospital of Jilin University, No. 126, Xiantai Street, Changchun, Jilin 130033, China. Hauptthemen laut MEDLINE: RNA Splicing Factors, RNA, Messenger, Active Transport, Cell Nucleus, Phosphoproteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Special Project for Health Research Talents of Jilin Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in SF3B1 are common in many types of cancer, promoting cancer progression through aberrant RNA splicing. Recently, mRNA nuclear export has been reported to be defective in cells with the SF3B1 K700E mutation. However, the mechanism remains unclear. Our study reveals that the K700E mutation in SF3B1 attenuates its interaction with THOC5, an essential component of the mRNA nuclear export complex THO. Furthermore, the SF3B1 mutation caused reduced binding of THOC5 with some mRNA and inhibited the nuclear export of these mRNAs. Interestingly, overexpression of THOC5 restores the nuclear export of these mRNAs in cells with the SF3B1 K700E mutation. Importantly, other types of cancer-associated SF3B1 mutations also inhibited mRNA nuclear export similarly, suggesting that it is common for cancer-associated SF3B1 mutations to inhibit mRNA nuclear export. Our research highlights the critical role of the THOC5–SF3B1 interaction in the regulation of mRNA nuclear export and provides valuable insights into the impact of SF3B1 mutations on mRNA nuclear export.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splicing FactorsRNA, MessengerActive Transport, Cell NucleusPhosphoproteinsMutationNeoplasmsHumansCell NucleusProtein BindingNuclear Proteins

Stichwörter der Autor:innen

SF3B1THOTHOC5U2 snRNPmRNA nuclear export

Substanzen

RNA Splicing FactorsSF3B1 protein, humanRNA, MessengerPhosphoproteinsTHOC5 protein, humanNuclear Proteins

Autor:innen und Institutionen

  • China-Japan Union Hospital of Jilin University, No. 126, Xiantai Street, Changchun, Jilin 130033, China.

ORCID-Profile: Youzhong Wan

Förderung

  • Special Project for Health Research Talents of Jilin Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, G., Zhao, B., Shi, Y., & Wan, Y. (2024). Cancer-associated SF3B1 mutations inhibit mRNA nuclear export by disrupting SF3B1–THOC5 interactions. The Journal of Biochemistry, 176(6), 437-448. https://doi.org/10.1093/jb/mvae061

Vancouver

Liu G, Zhao B, Shi Y, Wan Y. Cancer-associated SF3B1 mutations inhibit mRNA nuclear export by disrupting SF3B1–THOC5 interactions. The Journal of Biochemistry. 2024;176(6):437-448. doi:10.1093/jb/mvae061

BibTeX
@article{Liu2024,
  author = {Liu, Gang and Zhao, Bo and Shi, Yueru and Wan, Youzhong},
  title = {Cancer-associated SF3B1 mutations inhibit mRNA nuclear export by disrupting SF3B1–THOC5 interactions},
  journal = {The Journal of Biochemistry},
  year = {2024},
  volume = {176},
  number = {6},
  pages = {437--448},
  doi = {10.1093/jb/mvae061}
}
Kostenlos starten →